Gregor Warnecke

Nodir Madrahimov¹, 

Ruslan Natanov¹, 

Erin C. Boyle¹, 

Tobias Goecke¹, 

Ann-Kathrin Knöfel¹, 

Valentyna Irkha¹, 

Anna Solovieva², 

Klaus Höffler¹, 

Ulrich Maus³, 

Christian Kühn¹, 

Issam Ismail¹, 

Gregor Warnecke¹, 

Malakh-Lal Shrestha¹, 

Serghei Cebotari^*,1, 

Axel Haverich^*,1 

¹Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, 

²Department of Hematology, Oncology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, 

³Department of Pneumology, Hannover Medical School 

Vanessa Neuhaus^*,1, 

Olga Danov^*,1, 

Sebastian Konzok¹, 

Helena Obernolte¹, 

Susann Dehmel¹, 

Peter Braubach², 

Danny Jonigk², 

Hans-Gerd Fieguth³, 

Patrick Zardo⁴, 

Gregor Warnecke⁴, 

Christian Martin⁵, 

Armin Braun^1,6, 

Katherina Sewald¹ 

¹Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of REBIRTH Cluster of Excellence, 

²Institute for Pathology, Hannover Medical School, German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 

³Division of Thoracic and Vascular Surgery, Klinikum Region Hannover (KRH), 

⁴Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), Hannover Medical School, German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 

⁵Institute of Pharmacology and Toxicology, RWTH Aachen University, 

⁶Institute for Immunology, Hannover Medical School